Intracoastal Capital LLC Reports Zero Percent Stake in AIM ImmunoTech Inc. Following SPA Transaction

On May 27, 2026, Intracoastal Capital LLC, along with Mitchell P. Kopin and Daniel B. Asher, filed a Schedule 13G regarding their holdings in AIM ImmunoTech Inc. (AIM). The filing reveals that as of May 27, 2026, the reporting persons beneficially own zero shares of common stock, representing a 0.0% ownership stake. This follows a Securities Purchase Agreement (SPA) executed on May 20, 2026, under which Intracoastal was initially set to acquire 1,538,462 shares, which would have represented approximately 8.5% of the company. Additionally, the reporting persons hold warrants to purchase 3,076,924 shares; however, these warrants are currently excluded from beneficial ownership calculations because they are not exercisable until stockholder approval is obtained and are subject to a 4.99% blocker provision. The filing confirms that the reporting persons no longer hold the underlying common stock previously associated with the SPA transaction as of the filing date.